Bridgewater Associates’s BeOne Medicines Ltd ONC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-772	Closed	-$210K	–	747
2025 Q1	$210K	Sell	772 -838	-52%	-$196K	﹤0.01%	646
2024 Q4	$297K	Buy	+1,610	New	+$329K	﹤0.01%	630
2023 Q3	–	Sell	-12,118	Closed	-$2.16M	–	819
2023 Q2	$2.16M	Sell	12,118 -119,999	-91%	-$27.6M	0.01%	449
2023 Q1	$28.5M	Sell	132,117 -56,248	-30%	-$13.5M	0.17%	106
2022 Q4	$41.4M	Sell	188,365 -148,132	-44%	-$27.2M	0.23%	89
2022 Q3	$45.4M	Buy	336,497 +5,355	+2%	+$920K	0.23%	90
2022 Q2	$53.6M	Sell	331,142 -52,676	-14%	-$8.23M	0.23%	93
2022 Q1	$72.4M	Buy	383,818 +154,335	+67%	+$32.8M	0.29%	63
2021 Q4	$62.2M	Buy	229,483 +53,560	+30%	+$18.1M	0.36%	49
2021 Q3	$63.9M	Buy	175,923 +89,877	+104%	+$29.4M	0.35%	55
2021 Q2	$29.5M	Buy	86,046 +12,993	+18%	+$4.3M	0.19%	93
2021 Q1	$25.4M	Buy	73,053 +52,254	+251%	+$17.3M	0.22%	93
2020 Q4	$5.37M	Buy	+20,799	New	+$5.73M	0.05%	189